Printer Friendly
The Free Library
22,728,043 articles and books

Designer Drug ID methods sought.



The National Institute on Drug Abuse is seeking new ways to detect use of so-called "designer drugs designer drugs,
n.pl the synthetic organic compounds that are designed as analogs of illicit drugs and have the same narcotic or other dangerous effects.
" such as K2/Spice and Bath Salts based on their effects on the human body. Because "designer drugs" evolve constantly available structure-based drug screens. "This presents a substantial complication to traditional toxicology toxicology, study of poisons, or toxins, from the standpoint of detection, isolation, identification, and determination of their effects on the human body. Toxicology may be considered the branch of pharmacology devoted to the study of the poisonous effects of drugs.  screens conducted in emergency rooms and to drug testing laboratories, whose assays rely on either immunoassays or mass-spectrometry to detect specific agents," NIDA NIDA National Institute on Drug Abuse
NIDA National Institute of Dramatic Arts (Australia)
NIDA Northern Ireland Development Agency (UK)
NIDA Northern Ireland Dairy Association
 officials said. The institute intends to fund grants to researchers who are developing biofluid drug screens based on pharmacological activity of these designer drugs. The tests should be noninvasive and able to detect quantities of illicit materials or metabolites in a range of concentrations typically found in biofluids of substance users within a few days of use.
COPYRIGHT 2012 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:POLICY & PRACTICE
Author:Anderson, Jane
Publication:Internal Medicine News
Date:Apr 1, 2012
Words:129
Previous Article:Consumers eager to try exchanges.
Next Article:Match day: interest in primary care remains steady.
Topics:

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters